BDP1 and breast carcinoma: BDP1 mRNA expression correlates with ER and PR receptor expression in patients with metastatic breast cancer occurring three-year post-diagnosis (Figure 4A), patients with breast cancer recurring three years post initial diagnosis (Figure 4B) and correlated with death after three years (Figure 4C) and five years (Figure 4D).